The Ews/Fli-1 Fusion Gene Switches the Differentiation Program of Neuroblastomas to Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors

Cancer Research

Volumn 64, Issue 4, 2004, Pages 1266-1277

  Rorie, Checo J ^a,d   Thomas, Venetia D ^a,d,f   Chen, Pengchin ^b,d,g   Pierce, Heather Hanson ^c,d,h   O'Bryan, John P ^c,e   Weissman, Bernard E ^a,b,c,d  

^a Curriculum in Neurobiology   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Curriculum in Genetics and Molecular Biology   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g NuGEN Technologies Inc   (United States)

^h UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR FLI 1; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILDHOOD CANCER; CONTROLLED STUDY; DISEASE MARKER; EWING SARCOMA; EWS FLI 1 FUSION GENE; FUSION GENE; GENE EXPRESSION; GENE FUNCTION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYBRID CELL; NEURAL CREST CELL; NEUROBLASTOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; NEUROBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; PROTEINS; PROTO-ONCOGENE PROTEIN C-FLI-1; SARCOMA, EWING'S; TRANSCRIPTION FACTORS;

EID: 1242293672     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3274     Document Type: Article

References (91)

1. Black, C. T., and Atkinson, J. B. Neuroblastoma. Semin. Pediatr. Surg., 6: 2-10, 1997.
2. Brodeur, G. M. Molecular basis for heterogeneity in human neuroblastomas. Eur. J. Cancer, 31A: 505-510, 1995.
3. Chen, P., Lin, H. H., and Weissman, B. E. A functional analysis of tumor suppressor activity for peripheral neuroepitheliomas by monochromosome transfer. Oncogene, 10: 577-586, 1995.
4. Fletcher, J. A. Cytogenetics and experimental models of sarcomas. Curr. Opin. Oncol., 6: 367-371, 1994.
5. Joshi, V. V., and Silverman, J. F. Pathology of neuroblastic tumors. Semin. Diagn. Pathol., 11: 107-117, 1994.
6. Navarro, S., Cavazzana, A. O., Llombart-Bosch, A., and Triche, T. J. Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma. An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms. Arch. Pathol. Lab. Med., 118: 608-615, 1994.
7. Pagani, A., Macri, L., Rosolen, A., Toffolatti, L., Stella, A., and Bussolati, G. Neuroendocrine differentiation in Ewing's sarcomas and primitive neuroectodermal tumors revealed by reverse transcriptase-polymerase chain reaction of chromogranin mRNA. Diagn. Mol. Pathol., 7: 36-43, 1998.
8. Grier, H. E. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. Pediatr. Clin. North Am., 44: 991-1004, 1997.
9. Kelly, D. R., and Joshi, V. V. Neuroblastoma and related tumors. In: D. M. Parham (ed.), Pediatric Neoplasia: Morphology and Biology, pp. 105-152. Philadelphia: Lippincott-Raven, 1996.
10. Hedborg, F., Bjelfman, C., Sparen, P., Sandstedt, B., and Pahlman, S. Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome. Eur. J. Cancer, 31A: 435-443, 1995.
11. Tanaka, T., Sugimoto, T., and Sawada, T. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening. Cancer (Phila.), 83: 1626-1633, 1998.
12. Nakagawara, A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum. Cell, 11: 115-124, 1998.
13. Cooper, M. J., Hutchins, G. M., Cohen, P. S., Helman, L. J., Mennie, R. J., and Israel, M. A. Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Differ., 1: 149-159, 1990.
14. Cooper, M. J., Hutchins, G. M., Mennie, R. J., and Israel, M. A. β2-Microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation. Cancer Res., 50: 3694-3700, 1990.
15. Parham, D. M. Ewing's sarcoma, peripheral neuroepithelioma, and related tumors. In: D. M. Parham (ed.), Pediatric Neoplasia: Morphology and Biology, pp. 65-85. Philadelphia: Lippincott-Raven, 1996.
16. May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., and Denny, C. T. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FL11 for transformation. Proc. Natl. Acad. Sci. USA, 90: 5752-5756, 1993.
17. Ohno, T., Rao, V. N., and Reddy, E. S. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res., 53: 5859-5863, 1993.
18. Lessnick, S. L., Braun, B. S., Denny, C. T., and May, W. A. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene, 10: 423-431, 1995.
19. Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (Lond.), 359: 162-165, 1992.
20. Denny, C. T. Gene rearrangements in Ewing's sarcoma. Cancer Investig., 14: 83-88, 1996.
21. Bailly, R. A., Bosselut, R., Zucman, J., Cormier, F., Delattre, O., Roussel, M., Thomas, G., and Ghysdael, J. DNA-binding and transcriptional activation properties of the EWS-FL1-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol. Cell. Biol., 14: 3230-3241, 1994.
22. Delattre, O., Zucman, J., Melot, T., Garau, X. S., Zucker, J. M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., et al. The Ewing family of tumors: a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N. Engl. J. Med., 331: 294-299, 1994.
23. Thiele, C. J., McKeon, C., Triche, T. J., Ross, R. A., Reynolds, C. P., and Israel, M. A. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J. Clin. Investig., 80: 804-811, 1987.
24. Rossow, K. L., and Janknecht, R. The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res., 61: 2690-2695, 2001.
25. Chee, M., Yang, R., Hubbell, E., Berno, A., Huang, X. C., Stem, D., Winkler, J., Lockhart, D. J., Morris, M. S., and Fodor, S. P. Accessing genetic information with high-density DNA arrays. Science (Wash. DC), 274: 610-614, 1996.
26. Yap, G. Affymetrix, Inc. Pharmacogenomics, 3: 709-711, 2002.
27. Mutch, D. M., Berger, A., Mansourian, R., Rytz, A., and Roberts, M. A. Microarray data analysis: a practical approach for selecting differentially expressed genes. Genome Biol., 2: PREPRINT0009, 2001.
28. Davidson, R. L., and Gerald, P. S. Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet., 2: 165-176, 1976.
29. Kirschmeier, P. T., Housey, G. M., Johnson, M. D., Perkins, A. S., and Weinstein, I. B. Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. DNA, 7: 219-225, 1988.
30. Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M., and Arai, N. SR α promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type I long terminal repeat. Mol. Cell. Biol., 8: 466-472, 1988.
31. Zucman, J., Melot, T., Desmaze, C., Ghysdael, J., Plougastel, B., Peter, M., Zucker, J. M., Triche, T. J., Sheer, D., Turc-Carel, C., et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J., 12: 4481-4487, 1993.
32. Zoubek, A., Pfleiderer, C., Salzer-Kuntschik, M., Amann, G., Windhager, R., Fink, F. M., Koscielniak, E., Delattre, O., Strehl, S., Ambros, P. F., et al. Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. Br. J. Cancer, 70: 908-913, 1994.
33. Sambrook, J., Fritsch, E. F., and Maniatis, T. Extraction, purification, and analysis of messenger RNA from eukaryotic cells, In: C. Nolan (ed.), Molecular Cloning: A Laboratory Manual, Vol. 1, pp. 7.3-7.84. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
34. O'Bryan, J. P., Songyang, Z., Cantley, L., Der, C. J., and Pawson, T. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain. Proc. Natl. Acad. Sci. USA, 93: 2729-2734, 1996.
35. Nelson-Rees, W. A., Zhdanov, V. M., Hawthorne, P. K., and Flandermeyer, R. R. HeLa-like marker chromosomes and type-A variant glucose-6-phosphate dehydrogenase isoenzyme in human cell cultures producing Mason-Pfizer monkey virus-like particles. J. Natl. Cancer Inst. (Bethesda), 53: 751-757, 1974.
36. Chen, P., Ellmore, N., and Weissman, B. E. Functional evidence for a second tumor suppressor gene on human chromosome 17. Mol. Cell. Biol., 14: 534-542, 1994.
37. Chansky, H. A., Hu, M., Hickstein, D. D., and Yang, L. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res., 61: 3586-3590, 2001.
38. May, W. A., Arvand, A., Thompson, A. D., Braun, B. S., Wright, M., and Denny, C. T. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat. Genet., 17: 495-497, 1997.
39. Singh, N., Phillips, R. A., Iscove, N. N., and Egan, S. E. Expression of notch receptors, notch ligands, and fringe genes in hematopoiesis. Exp. Hematol., 28: 527-534, 2000.
40. Ishii, Y., Nakamura, S., and Osumi, N. Demarcation of early mammalian cortical development by differential expression of fringe genes. Brain Res. Dev. Brain Res., 119: 307-320, 2000.
41. Thelu, J., Viallet, J. P., and Dhouailly, D. Differential expression pattern of the three Fringe genes is associated with epidermal differentiation. J. Investig. Dermatol., 111: 903-906, 1998.
42. Hahm, K. B., Cho, K., Lee, C., Im, Y. H., Chang, J., Choi, S. G., Sorensen, P. H., Thiele, C. J., and Kim, S. J. Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLII oncoprotein. Nat. Genet., 23: 222-227, 1999.
43. Lutz, M., and Knaus, P. Integration of the TGF-β pathway into the cellular signalling network. Cell Signalling, 14: 977-988, 2002.
44. Nakamura, T., Sanokawa, R., Sasaki, Y., Ayusawa, D., Oishi, M., and Mori, N. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway. Oncogene, 13: 1111-1121, 1996.
45. Obermeier, A., Bradshaw, R. A., Seedorf, K., Choidas, A., Schlessinger, J., and Ullrich, A. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC γ. EMBO J., 13: 1585-1590, 1994.
46. Stephens, R. M., Loeb, D. M., Copeland, T. D., Pawson, T., Greene, L. A., and Kaplan, D. R. Trk receptors use redundant signal transduction pathways involving SHC and PLC-γ I to mediate NGF responses. Neuron, 12: 691-705, 1994.
47. Cattaneo, E., and Pelicci, P. G. Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain. Trends Neurosci., 21: 476-481, 1998.
48. Conti, L., De Fraja, C., Gulisano, M., Migliaccio, E., Govoni, S., and Cattaneo, E. Expression and activation of SH2/PTB-containing ShcA adaptor protein reflects the pattern of neurogenesis in the mammalian brain. Proc. Natl. Acad. Sci. USA, 94: 8185-8190, 1997.
49. Ganju, P., O'Bryan, J. P., Der, C., Winter, J., and James, I. F. Differential regulation of SHC proteins by nerve growth factor in sensory neurons and PC12 cells. Eur. J. Neurosci., 10: 1995-2008, 1998.
50. Sakai, R., Henderson, J. T., O'Bryan, J. P., Elia, A. J., Saxton, T. M., and Pawson, T. The mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons. Neuron, 28: 819-833, 2000.
51. Barbacid, M. Structural and functional properties of the TRK family of neurotrophin receptors. Ann. N. Y. Acad. Sci., 766: 442-458, 1995.
52. Klein, R., Conway, D., Parada, L. F., and Barbacid, M. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell, 61: 647-656, 1990.
53. Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H., and Brown, E. L. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol., 14: 1675-1680, 1996.
54. Huang, S., Qian, H. R., Geringer, C., Love, C., Gelbert, L., and Bemis, K. Assessing the variability in GeneChip data. Am. J. Pharmacogenomics, 3: 279-290, 2003.
55. Zapala, M. A., Lockhart, D. J., Pankratz, D. G., Garcia, A. J., and Barlow, C. Software and methods for oligonucleotide and cDNA array data analysis. Genome Biol., 3: 6 SOFTWARE0001, 2002.
56. Weiss, M. C., and Chaplain, M. Expression of differentiated functions in hepatoma cell hybrids: reappearance of tyrosine aminotransferase inducibility after the loss of chromosomes. Proc. Natl. Acad. Sci. USA, 68: 3026-3030, 1971.
57. Weiss, M. C., Sparkes, R. S., and Bertolotti, R. Expression of differentiated functions in hepatoma cell hybrids: IX extinction and reexpression of liver-specific enzymes in rat hepatoma-Chinese hamster fibroblast hybrids. Somatic Cell Genet., 1: 27-40, 1975.
58. Killary, A. M., and Fournier, R. E. A genetic analysis of extinction: trans-dominant loci regulate expression of liver-specific traits in hepatoma hybrid cells. Cell, 38: 523-534, 1984.
59. Schneider, J. A., and Weiss, M. C. Expression of differentiated functions in hepatoma cell hybrids. I. Tyrosine aminotransferase in hepatoma-fibroblast hybrids. Proc. Natl. Acad. Sci. USA, 68: 127-131, 1971.
60. Epperlein, H., Meulemans, D., Bronner-Fraser, M., Steinbeisser, H., and Selleck, M. A. Analysis of cranial neural crest migratory pathways in axolotl using cell markers and transplantation. Development (Camb.), 127: 2751-2761, 2000.
61. Gaetano, C., Manni, I., Bossi, G., Piaggio, G., Soddu, S., Farina, A., Helman, L. J., and Sacchi, A. Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cells. Eur. J. Cancer, 31A: 447-452, 1995.
62. Jensen, D. E., Black, A. R., Swick, A. G., and Azizkhan, J. C. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J. Cell. Biochem., 67: 24-31, 1997.
63. Izumi, M., Yokoi, M., Nishikawa, N. S., Miyazawa, H., Sugino, A., Yamagishi, M., Yamaguchi, M., Matsukage, A., Yatagai, F., and Hanaoka, F. Transcription of the catalytic 180-kDa subunit gene of mouse DNA polymerase α is controlled by E2F, an Ets-related transcription factor, and Sp1. Biochim. Biophys. Acta, 1492: 341-352, 2000.
64. Braghetti, A., Piazzi, G., Lanfranco, L., and Mondello, C. Multiple DNA-protein interactions at the CpG island of the human pseudoautosomal gene MIC2. Somatic Cell Mol. Genet., 19: 51-63, 1993.
65. Dworzak, M., Stock, C., Strehl, S., Gadner, H., and Ambros, P. F. Ewing's tumor X mouse hybrids expressing the MIC2 antigen: analyses using fluorescence CDD-banding and non-isotopic ISH. Hum. Genet., 88: 273-278, 1992.
66. Dauphinot, L., De Oliveira, C., Melot, T., Sevenet, N., Thomas, V., Weissman, B. E., and Delattre, O. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene, 20: 3258-3265, 2001.
67. Lin, S. Y., Black, A. R., Kostic, D., Pajovic, S., Hoover, C. N., and Azizkhan, J. C. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol., 16: 1668-1675, 1996.
68. Slansky, J. E., and Farnham, P. J. Transcriptional regulation of the dihydrofolate reductase gene. Bioessays, 18: 55-62, 1996.
69. Pagani, A., Fischer-Colbrie, R., Eder, U., Pellin, A., Llombart-Bosch, A., and Bussolati, G. Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence. Int. J. Cancer, 63: 738-743, 1995.
70. Maroulakou, I. G., and Bowe, D. B. Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene, 19: 6432-6442, 2000.
71. Pereira, R., Quang, C. T., Lesault, I., Dolznig, H., Beug, H., and Ghysdael, J. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene, 18: 1597-1608, 1999.
72. Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., Gerbing, R. B., and Reynolds, C. P. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N. Engl. J. Med., 341: 1165-1173, 1999.
73. Bader, S. A., Fasching, C., Brodeur, G. M., and Stanbridge, E. J. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ., 2: 245-255, 1991.
74. Maris, J. M., and Matthay, K. K. Molecular biology of neuroblastoma. J. Clin. Oncol., 17: 2264-2279, 1999.
75. Laureys, G., Speleman, F., Versteeg, R., van der Drift, P., Chan, A., Leroy, J., Francke, U., Opdenakker, G., and Van Roy, N. Constitutional translocation t(1; 17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NFI/SCYA7 on chromosome 17 as breakpoint flanking single copy markers. Oncogene, 10: 1087-1093, 1995.
76. Guo, C., White, P. S., Weiss, M. J., Hogarty, M. D., Thompson, P. M., Stram, D. O., Gerbing, R., Matthay, K. K., Seeger, R. C., Brodeur, G. M., and Maris, J. M. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene, 18: 4948-4957, 1999.
77. Torchia, E. C., Jaishankar, S., and Baker, S. J. Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res., 63: 3464-3468, 2003.
78. Mehra, A., and Wrana, J. L. TGF-β and the Smad signal transduction pathway. Biochem. Cell Biol., 80: 605-622, 2002.
79. Athanasiou, M., LeGallic, L., Watson, D. K., Blair, D. G., and Mavrothalassitis, G. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids. Cancer Gene Ther., 7: 1188-1195, 2000.
80. Donnellan, R., and Chetty, R. Cyclin D1 and human neoplasia. Mol. Pathol., 51: 1-7, 1998.
81. Stacey, D. W. Cyclin DI serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell Biol., 15: 158-163, 2003.
82. 1 regulatory genes. Br. J. Cancer, 84: 768-775, 2001.
83. Wai, D. H., Schaefer, K. L., Schramm, A., Korsching, E., Van Valen, F., Ozaki, T., Boecker, W., Schweigerer, L., Dockhom-Dwomiczak, B., and Poremba, C. Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int. J. Oncol., 20: 441-451, 2002.
84. Nishimori, H., Sasaki, Y., Yoshida, K., Irifune, H., Zembutsu, H., Tanaka, T., Aoyama, T., Hosaka, T., Kawaguchi, S., Wada, T., Hata, J., Toguchida, J., Nakamura, Y., and Tokino, T. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene, 21: 8302-8309, 2002.
85. Fukuma, M., Okita, H., Hata, J., and Umezawa, A. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Oncogene, 22: 1-9, 2003.
86. Alway, S. E., Martyn, J. K., Ouyang, J., Chaudhrai, A., and Murlasits, Z. S. Id2 expression during apoptosis and satellite cell activation in unloaded and loaded quail skeletal muscles. Am. J. Physiol. Regul. Integr. Comp. Physiol., 284: R540-R549, 2003.
87. Lee, M. H., and Yang, H. Y. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol. Life Sci., 58: 1907-1922, 2001.
88. Seeger, R. C., Danon, Y. L., Rayner, S. A., and Hoover, F. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J. Immunol., 128: 983-989, 1982.
89. Brodeur, G. M., Sekhon, G., and Goldstein, M. N. Chromosomal aberrations in human neuroblastomas. Cancer (Phila.), 40: 2256-2263, 1977.
90. Giard, D. J., Aaronson, S. A., Todaro, G. J., Amstein, P., Kersey, J. H., Dosik, H., and Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst. (Bethesda), 51: 1417-1423, 1973.
91. Biedler, J. L., Helson, L., and Spengler, B. A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res., 33: 2643-2652, 1973.